Arthritis - US


February 1, 2011
77 Pages - SKU: GN6168450
License type:
Countries covered: United States

Coping with changes, managing pain

Many products promise pain relief from a variety of symptoms, from general aches and pains to headaches and migraines. Few, however, are positioned to meet the needs of arthritis sufferers. Oral and topical analgesics that are specially formulated for the treatment of arthritis pain and marketed to this demographic may meet with success, especially in light of Tylenol’s product recalls (Tylenol’s Arthritis Pain dominates the arthritis-specific internal analgesic tablets sub-segment).

Mintel’s exclusive consumer research shows that respondents with arthritis are interested in products for pain relief that have minimal side effects. Although the claim “natural” does not necessarily mean free of side effects, such ingredients suggest less impact on the body. Products with natural, yet effective, ingredients may have a real appeal to arthritis sufferers.



More United States Rheumatology/Arthritis reports

MediPoint: Total Wrist Reconstruction - US Analysis and Market Forecasts by GlobalData
MediPoint: Total Wrist Reconstruction - US Analysis and Market ForecastsSummaryInjuries to any of the bones, ligaments, tendons or nerves in the wrist joint can cause ...
PharmaPoint: Rheumatoid Arthritis - United States Drug Forecast and Market Analysis Event-Driven Update by GlobalData
PharmaPoint: Rheumatoid Arthritis - United States Drug Forecast and Market Analysis Event-Driven UpdateSummaryGlobalData has released its new Country report, “PharmaPoint: Rheumatoid Arthritis - United States ...
TreatmentTrends®: Rheumatoid Arthritis US (Wave 3) 2012 by Decision Resources
TreatmentTrends® Biologics in Rheumatoid Arthritis is a report that covers the use of biologics for the treatment of RA. The report, part of a quarterly ...
ChartTrends®: Rheumatoid Arthritis (US) 2012 by Decision Resources
This report is an annual publication that provides comprehensive insight into the management of rheumatoid arthritis (RA) patients being treated with biologics based on actual ...
See all reports like this >>

More United States reports

The 2013-2018 Outlook for Relish in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for relish across the states and cities of the United States. Latent demand (in millions of U.S. ...
The 2013-2018 Outlook for Indian Breads in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for Indian breads across the states and cities of the United States. Latent demand (in millions of ...
D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
See all reports like this >>